1. Home
  2. CMP vs WVE Comparison

CMP vs WVE Comparison

Compare CMP & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Minerals Intl Inc

CMP

Compass Minerals Intl Inc

HOLD

Current Price

$29.38

Market Cap

1.3B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMP
WVE
Founded
1993
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
CMP
WVE
Price
$29.38
$5.82
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$21.50
$29.81
AVG Volume (30 Days)
375.0K
2.6M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.73
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.29
$85.67
P/E Ratio
$40.88
N/A
Revenue Growth
N/A
149.43
52 Week Low
$16.40
$5.02
52 Week High
$34.50
$21.73

Technical Indicators

Market Signals
Indicator
CMP
WVE
Relative Strength Index (RSI) 45.83 45.35
Support Level $28.05 $5.49
Resistance Level $32.31 $6.48
Average True Range (ATR) 0.98 0.27
MACD -0.01 -0.01
Stochastic Oscillator 42.06 32.81

Price Performance

Historical Comparison
CMP
WVE

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: